Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Women’s Health Market

ID: MRFR/HC/2248-CR
200 Pages
Satyendra Maurya
Last Updated: May 15, 2026

Women’s Health Market Research Report: Information by Product (Contraceptive, Fertility and Ovulation Induction Drugs, Vaginal and Uterine Products, Bone Health Agents, Pain and Symptom Management, Others), By Therapeutic Area (Reproductive Health and Fertility, Menopause and Hormonal Disorders, Gynecological Disorders and Others), By Age Group (Below 30, 31-40, 41-50, and Above 51), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Supermarket and Hypermarket, Online Channels and others)By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) -Global Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Women Healthcare Market Infographic
Purchase Options
  1. 1 EXECUTIVE SUMMARY
    1. 1.1 OVERVIEW
    2. 1.2 MARKET ATTRACTIVENESS ANALYSIS
    3. 1.3 GLOBAL WOMEN’S HEALTH MARKET, BY PRODUCT
    4. 1.4 GLOBAL WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA
    5. 1.5 GLOBAL WOMEN’S HEALTH MARKET, BY AGE GROUP
    6. 1.6 GLOBAL WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL
    7. 1.7 GLOBAL WOMEN’S HEALTH MARKET, BY REGION
  2. 2 MARKET INTRODUCTION
    1. 2.1 DEFINITION
    2. 2.2 SCOPE OF THE STUDY
    3. 2.3 RESEARCH OBJECTIVE
    4. 2.4 MARKET STRUCTURE
  3. 3 RESEARCH METHODOLOGY
    1. 3.1 OVERVIEW
    2. 3.2 DATA FLOW
      1. 3.2.1 Data Mining Process
    3. 3.3 PURCHASED DATABASE:
    4. 3.4 SECONDARY SOURCES:
      1. 3.4.1 Secondary Research data flow:
    5. 3.5 PRIMARY RESEARCH:
      1. 3.5.1 Primary Research Data Flow:
      2. 3.5.2 Primary Research: Number of Interviews conducted
    6. 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
      1. 3.6.1 Revenue Analysis Approach
    7. 3.7 DATA FORECASTING
      1. 3.7.1 Data forecasting Type
    8. 3.8 DATA MODELING
      1. 3.8.1 microeconomic factor analysis:
      2. 3.8.2 Data modeling:
    9. 3.9 TEAMS AND ANALYST CONTRIBUTION
  4. 4 MARKET DYNAMICS
    1. 4.1 INTRODUCTION
    2. 4.2 DRIVERS
      1. 4.2.1 Rising contraceptive use
      2. 4.2.2 Increasing infertility
      3. 4.2.3 Aging female population
      4. 4.2.4 Rising gynecological disorders
    3. 4.3 RESTRAINTS
      1. 4.3.1 Hormonal therapy side effects
      2. 4.3.2 Cultural Stigma and Social Barriers
      3. 4.3.3 Limited healthcare access
    4. 4.4 OPPORTUNITIES
      1. 4.4.1 Rapid Expansion of FemTech and digital health
      2. 4.4.2 Development of Non-hormonal therapies
  5. 5 MARKET FACTOR ANALYSIS
    1. 5.1 REGULATORY ENVIRONMENT & COMPLIANCE
    2. 5.2 TECHNOLOGICAL TRENDS & INNOVATION
    3. 5.3 PATIENT DEMOGRAPHICS & DISEASE BURDENS
    4. 5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS
      1. 5.4.1 PRICING ANALYSIS
        1. 5.4.1.1 North America
        2. 5.4.1.2 Europe
        3. 5.4.1.3 Asia Pacific
        4. 5.4.1.4 Latin America
        5. 5.4.1.5 Middle East & Africa
      2. 5.4.2 REIMBURSEMENT DYNAMICS
    5. 5.5 MARKET ENTRY & EXIT BARRIERS
      1. 5.5.1 BARRIERS TO ENTRY
      2. 5.5.2 BARRIERS TO EXIT
    6. 5.6 PARTNERSHIPS & COLLABORATIONS
    7. 5.7 CONSUMER & HEALTHCARE PROVIDER PREFERENCES
      1. 5.7.1 CONSUMER PREFERENCES
      2. 5.7.2 HEALTHCARE PROVIDER PREFERENCES
    8. 5.8 PESTLE ANALYSIS
      1. 5.8.1 POLITICAL FACTORS
      2. 5.8.2 ECONOMIC FACTORS
      3. 5.8.3 SOCIAL FACTORS
      4. 5.8.4 TECHNOLOGICAL FACTORS
      5. 5.8.5 LEGAL FACTORS
      6. 5.8.6 ENVIRONMENTAL FACTORS
    9. 5.9 PORTER'S FIVE FORCES MODEL
      1. 5.9.1 Threat of New Entrants
      2. 5.9.2 Bargaining Power of Suppliers
      3. 5.9.3 Bargaining Power of Buyers
      4. 5.9.4 Threat of Substitutes
      5. 5.9.5 Intensity of Rivalry
    10. 5.10 PRODUCT PIPELINE ANALYSIS
    11. 5.11 CASE STUDY ANALYSIS
    12. 5.12 INVESTMENT & FUNDING SCENARIOS
    13. 5.13 POST-MARKET SURVEILLANCE & SAFETY DATA
    14. 5.14 DISEASE OVERVIEW
    15. 5.15 DIAGNOSIS
    16. 5.16 CURRENT TREATMENT
  6. 6 GLOBAL WOMEN’S HEALTH MARKET, BY PRODUCT
    1. 6.1 OVERVIEW
  7. 7 GLOBAL WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA
    1. 7.1 OVERVIEW
  8. 8 GLOBAL WOMEN’S HEALTH MARKET, BY AGE GROUP
    1. 8.1 OVERVIEW
  9. 9 GLOBAL WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL
    1. 9.1 OVERVIEW
  10. 10 GLOBAL WOMEN’S HEALTH MARKET, BY REGION
    1. 10.1 OVERVIEW
    2. 10.2 NORTH AMERICA
      1. 10.2.1 US
      2. 10.2.2 Canada
    3. 10.3 EUROPE
      1. 10.3.1 Germany
      2. 10.3.2 UK
      3. 10.3.3 France
      4. 10.3.4 Netherlands
      5. 10.3.5 Italy
      6. 10.3.6 Spain
      7. 10.3.7 Rest of Europe
    4. 10.4 ASIA-PACIFIC
      1. 10.4.1 China
      2. 10.4.2 India
      3. 10.4.3 Japan
      4. 10.4.4 South Korea
      5. 10.4.5 Malaysia
      6. 10.4.6 Thailand
      7. 10.4.7 Indonesia
      8. 10.4.8 Rest of APAC
    5. 10.5 LATIN AMERICA
      1. 10.5.1 Brazil
      2. 10.5.2 Mexico
      3. 10.5.3 Argentina
      4. 10.5.4 Rest of Latin America
    6. 10.6 MIDDLE EAST & AFRICA
      1. 10.6.1 GCC Countries
      2. 10.6.2 South Africa
      3. 10.6.3 Rest of MEA
  11. 11 COMPETITIVE LANDSCAPE
    1. 11.1 INTRODUCTION
    2. 11.2 MARKET SHARE ANALYSIS, 2025
    3. 11.3 COMPETITOR DASHBOARD
    4. 11.4 KEY DEVELOPMENTS
  12. 12 COMPANY PROFILES
    1. 12.1 BAYER AG
      1. 12.1.1 COMPANY OVERVIEW
      2. 12.1.2 FINANCIAL OVERVIEW
      3. 12.1.3 PRODUCTS OFFERED
      4. 12.1.4 SWOT ANALYSIS
      5. 12.1.5 KEY STRATEGIES
    2. 12.2 MERCK KGAA
      1. 12.2.1 COMPANY OVERVIEW
      2. 12.2.2 FINANCIAL OVERVIEW
      3. 12.2.3 PRODUCTS OFFERED
      4. 12.2.4 SWOT ANALYSIS
      5. 12.2.5 KEY STRATEGIES
    3. 12.3 PFIZER
      1. 12.3.1 COMPANY OVERVIEW
      2. 12.3.2 PRODUCTS OFFERED
      3. 12.3.3 SWOT ANALYSIS
      4. 12.3.4 FINANCIAL ANALYSIS
      5. 12.3.5 KEY STRATEGY
    4. 12.4 RECKITT BENCKISER
      1. 12.4.1 COMPANY OVERVIEW
      2. 12.4.2 PRODUCTS OFFERED
      3. 12.4.3 SWOT ANALYSIS
      4. 12.4.4 FINANCIAL ANALYSIS
      5. 12.4.5 KEY STRATEGY
    5. 12.5 CHURCH & DWIGHT CO., INC.
      1. 12.5.1 COMPANY OVERVIEW
      2. 12.5.2 PRODUCTS OFFERED
      3. 12.5.3 SWOT ANALYSIS
      4. 12.5.4 FINANCIAL ANALYSIS
      5. 12.5.5 KEY STRATEGY
    6. 12.6 ABBVIE INC.
      1. 12.6.1 COMPANY OVERVIEW
      2. 12.6.2 PRODUCTS OFFERED
      3. 12.6.3 SWOT ANALYSIS
      4. 12.6.4 FINANCIAL ANALYSIS
      5. 12.6.5 KEY STRATEGY
    7. 12.7 ORGANON & CO.
      1. 12.7.1 COMPANY OVERVIEW
      2. 12.7.2 PRODUCTS OFFERED
      3. 12.7.3 SWOT ANALYSIS
      4. 12.7.4 FINANCIAL ANALYSIS
      5. 12.7.5 KEY STRATEGY
    8. 12.8 MERCK & CO
      1. 12.8.1 COMPANY OVERVIEW
      2. 12.8.2 PRODUCTS OFFERED
      3. 12.8.3 SWOT ANALYSIS
      4. 12.8.4 FINANCIAL ANALYSIS
      5. 12.8.5 KEY STRATEGY
    9. 12.9 FERRING PHARMACEUTICALS
      1. 12.9.1 COMPANY OVERVIEW
      2. 12.9.2 PRODUCTS OFFERED
      3. 12.9.3 SWOT ANALYSIS
      4. 12.9.4 FINANCIAL ANALYSIS
      5. 12.9.5 KEY STRATEGY
    10. 12.10 AMGEN
      1. 12.10.1 COMPANY OVERVIEW
      2. 12.10.2 PRODUCTS OFFERED
      3. 12.10.3 SWOT ANALYSIS
      4. 12.10.4 FINANCIAL ANALYSIS
  13. 13 DATA CITATIONS
  14. LIST OF TABLES
  15. TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  16. TABLE 2 PRODUCT PIPELINE
  17. TABLE 3 GLOBAL WOMEN’S HEALTH MARKET, BY PRODUCT, 2019-2035 (USD MILLION)
  18. TABLE 4 GLOBAL WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  19. TABLE 5 GLOBAL WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  20. TABLE 6 GLOBAL WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  21. TABLE 7 GLOBAL WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  22. TABLE 8 GLOBAL WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  23. TABLE 9 GLOBAL WOMEN’S HEALTH MARKET, BY AGE GROUP, 2019-2035 (USD MILLION)
  24. TABLE 10 GLOBAL WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  25. TABLE 11 GLOBAL WOMEN’S HEALTH MARKET, BY REGION, 2019-2035 (USD MILLION)
  26. TABLE 12 NORTH AMERICA WOMEN’S HEALTH MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  27. TABLE 13 NORTH AMERICA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  28. TABLE 14 NORTH AMERICA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  29. TABLE 15 NORTH AMERICA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  30. TABLE 16 NORTH AMERICA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  31. TABLE 17 NORTH AMERICA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  32. TABLE 18 NORTH AMERICA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  33. TABLE 19 NORTH AMERICA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  34. TABLE 20 NORTH AMERICA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  35. TABLE 21 US WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  36. TABLE 22 US WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  37. TABLE 23 US WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  38. TABLE 24 US WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  39. TABLE 25 US WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  40. TABLE 26 US WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  41. TABLE 27 US WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  42. TABLE 28 US WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  43. TABLE 29 CANADA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  44. TABLE 30 CANADA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  45. TABLE 31 CANADA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  46. TABLE 32 CANADA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  47. TABLE 33 CANADA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  48. TABLE 34 CANADA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  49. TABLE 35 CANADA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  50. TABLE 36 CANADA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  51. TABLE 37 EUROPE WOMEN’S HEALTH MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  52. TABLE 38 EUROPE WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  53. TABLE 39 EUROPE WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  54. TABLE 40 EUROPE WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  55. TABLE 41 EUROPE WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  56. TABLE 42 EUROPE WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  57. TABLE 43 EUROPE WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  58. TABLE 44 EUROPE WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  59. TABLE 45 EUROPE WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  60. TABLE 46 GERMANY WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  61. TABLE 47 GERMANY WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  62. TABLE 48 GERMANY WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  63. TABLE 49 GERMANY WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  64. TABLE 50 GERMANY WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  65. TABLE 51 GERMANY WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  66. TABLE 52 GERMANY WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  67. TABLE 53 GERMANY WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  68. TABLE 54 UK WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  69. TABLE 55 UK WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  70. TABLE 56 UK WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  71. TABLE 57 UK WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  72. TABLE 58 UK WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  73. TABLE 59 UK WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  74. TABLE 60 UK WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  75. TABLE 61 UK WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  76. TABLE 62 FRANCE WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  77. TABLE 63 FRANCE WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  78. TABLE 64 FRANCE WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  79. TABLE 65 FRANCE WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  80. TABLE 66 FRANCE WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  81. TABLE 67 FRANCE WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  82. TABLE 68 FRANCE WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  83. TABLE 69 FRANCE WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  84. TABLE 70 NETHERLANDS WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  85. TABLE 71 NETHERLANDS WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  86. TABLE 72 NETHERLANDS WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  87. TABLE 73 NETHERLANDS WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  88. TABLE 74 NETHERLANDS WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  89. TABLE 75 NETHERLANDS WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  90. TABLE 76 NETHERLANDS WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  91. TABLE 77 NETHERLANDS WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  92. TABLE 78 ITALY WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  93. TABLE 79 ITALY WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  94. TABLE 80 ITALY WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  95. TABLE 81 ITALY WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  96. TABLE 82 ITALY WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  97. TABLE 83 ITALY WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  98. TABLE 84 ITALY WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  99. TABLE 85 ITALY WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  100. TABLE 86 SPAIN WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  101. TABLE 87 SPAIN WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  102. TABLE 88 SPAIN WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  103. TABLE 89 SPAIN WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  104. TABLE 90 SPAIN WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  105. TABLE 91 SPAIN WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  106. TABLE 92 SPAIN WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  107. TABLE 93 SPAIN WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  108. TABLE 94 REST OF EUROPE WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  109. TABLE 95 REST OF EUROPE WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  110. TABLE 96 REST OF EUROPE WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  111. TABLE 97 REST OF EUROPE WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  112. TABLE 98 REST OF EUROPE WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  113. TABLE 99 REST OF EUROPE WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  114. TABLE 100 REST OF EUROPE WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  115. TABLE 101 REST OF EUROPE WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  116. TABLE 102 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  117. TABLE 103 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  118. TABLE 104 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  119. TABLE 105 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  120. TABLE 106 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  121. TABLE 107 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  122. TABLE 108 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  123. TABLE 109 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  124. TABLE 110 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  125. TABLE 111 CHINA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  126. TABLE 112 CHINA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  127. TABLE 113 CHINA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  128. TABLE 114 CHINA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  129. TABLE 115 CHINA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  130. TABLE 116 CHINA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  131. TABLE 117 CHINA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  132. TABLE 118 CHINA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  133. TABLE 119 INDIA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  134. TABLE 120 INDIA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  135. TABLE 121 INDIA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  136. TABLE 122 INDIA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  137. TABLE 123 INDIA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  138. TABLE 124 INDIA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  139. TABLE 125 INDIA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  140. TABLE 126 INDIA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  141. TABLE 127 JAPAN WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  142. TABLE 128 JAPAN WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  143. TABLE 129 JAPAN WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  144. TABLE 130 JAPAN WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  145. TABLE 131 JAPAN WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  146. TABLE 132 JAPAN WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  147. TABLE 133 JAPAN WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  148. TABLE 134 JAPAN WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  149. TABLE 135 SOUTH KOREA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  150. TABLE 136 SOUTH KOREA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  151. TABLE 137 SOUTH KOREA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  152. TABLE 138 SOUTH KOREA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  153. TABLE 139 SOUTH KOREA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  154. TABLE 140 SOUTH KOREA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  155. TABLE 141 SOUTH KOREA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  156. TABLE 142 SOUTH KOREA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  157. TABLE 143 MALAYSIA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  158. TABLE 144 MALAYSIA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  159. TABLE 145 MALAYSIA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  160. TABLE 146 MALAYSIA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  161. TABLE 147 MALAYSIA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  162. TABLE 148 MALAYSIA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  163. TABLE 149 MALAYSIA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  164. TABLE 150 MALAYSIA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  165. TABLE 151 THAILAND WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  166. TABLE 152 THAILAND WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  167. TABLE 153 THAILAND WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  168. TABLE 154 THAILAND WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  169. TABLE 155 THAILAND WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  170. TABLE 156 THAILAND WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  171. TABLE 157 THAILAND WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  172. TABLE 158 THAILAND WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  173. TABLE 159 INDONESIA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  174. TABLE 160 INDONESIA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  175. TABLE 161 INDONESIA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  176. TABLE 162 INDONESIA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  177. TABLE 163 INDONESIA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  178. TABLE 164 INDONESIA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  179. TABLE 165 INDONESIA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  180. TABLE 166 INDONESIA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  181. TABLE 167 REST OF ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  182. TABLE 168 REST OF ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  183. TABLE 169 REST OF ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  184. TABLE 170 REST OF ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  185. TABLE 171 REST OF ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  186. TABLE 172 REST OF REST OF EUROPE WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  187. TABLE 173 REST OF ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  188. TABLE 174 REST OF ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  189. TABLE 175 LATIN AMERICA WOMEN’S HEALTH MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  190. TABLE 176 LATIN AMERICA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  191. TABLE 177 LATIN AMERICA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  192. TABLE 178 LATIN AMERICA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  193. TABLE 179 LATIN AMERICA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  194. TABLE 180 LATIN AMERICA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  195. TABLE 181 LATIN AMERICA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  196. TABLE 182 LATIN AMERICA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  197. TABLE 183 LATIN AMERICA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  198. TABLE 184 BRAZIL WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  199. TABLE 185 BRAZIL WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  200. TABLE 186 BRAZIL WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  201. TABLE 187 BRAZIL WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  202. TABLE 188 BRAZIL WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  203. TABLE 189 BRAZIL WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  204. TABLE 190 BRAZIL WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  205. TABLE 191 BRAZIL WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  206. TABLE 192 MEXICO WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  207. TABLE 193 MEXICO WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  208. TABLE 194 MEXICO WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  209. TABLE 195 MEXICO WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  210. TABLE 196 MEXICO WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  211. TABLE 197 MEXICO WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  212. TABLE 198 MEXICO WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  213. TABLE 199 MEXICO WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  214. TABLE 200 ARGENTINA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  215. TABLE 201 ARGENTINA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  216. TABLE 202 ARGENTINA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  217. TABLE 203 ARGENTINA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  218. TABLE 204 ARGENTINA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  219. TABLE 205 ARGENTINA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  220. TABLE 206 ARGENTINA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  221. TABLE 207 ARGENTINA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  222. TABLE 208 REST OF LATIN AMERICA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  223. TABLE 209 REST OF LATIN AMERICA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  224. TABLE 210 REST OF LATIN AMERICA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  225. TABLE 211 REST OF LATIN AMERICA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  226. TABLE 212 REST OF LATIN AMERICA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  227. TABLE 213 REST OF LATIN AMERICA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  228. TABLE 214 REST OF LATIN AMERICA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  229. TABLE 215 REST OF LATIN AMERICA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  230. TABLE 216 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  231. TABLE 217 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  232. TABLE 218 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  233. TABLE 219 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  234. TABLE 220 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  235. TABLE 221 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  236. TABLE 222 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  237. TABLE 223 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  238. TABLE 224 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  239. TABLE 225 GCC COUNTRIES WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  240. TABLE 226 GCC COUNTRIES WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  241. TABLE 227 GCC COUNTRIES WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  242. TABLE 228 GCC COUNTRIES WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  243. TABLE 229 GCC COUNTRIES WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  244. TABLE 230 GCC COUNTRIES WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  245. TABLE 231 GCC COUNTRIES WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  246. TABLE 232 GCC COUNTRIES WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  247. TABLE 233 SOUTH AFRICA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  248. TABLE 234 SOUTH AFRICA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  249. TABLE 235 SOUTH AFRICA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  250. TABLE 236 SOUTH AFRICA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  251. TABLE 237 SOUTH AFRICA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  252. TABLE 238 SOUTH AFRICA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  253. TABLE 239 SOUTH AFRICA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  254. TABLE 240 SOUTH AFRICA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  255. TABLE 241 REST OF MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  256. TABLE 242 REST OF MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY CONTRACEPTIVES, 2019-2035 (USD MILLION)
  257. TABLE 243 REST OF MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY FERTILITY AND OVULATION INDUCTION DRUGS, 2019-2035 (USD MILLION)
  258. TABLE 244 REST OF MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY VAGINAL AND UTERINE PRODUCTS, 2019-2035 (USD MILLION)
  259. TABLE 245 REST OF MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY BONE HEALTH AGENTS, 2019-2035 (USD MILLION)
  260. TABLE 246 REST OF MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2019-2035 (USD MILLION)
  261. TABLE 247 REST OF MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY AGE GROUP 2019-2035 (USD MILLION)
  262. TABLE 248 REST OF MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL 2019-2035 (USD MILLION)
  263. TABLE 249 KEY DEVELOPMENTS: GLOBAL WOMEN’S HEALTH MARKET
  264. TABLE 250 BAYER AG: PRODUCTS OFFERED
  265. TABLE 251 MERCK KGAA.: PRODUCT OFFERED
  266. TABLE 252 PFIZER: PRODUCT OFFERED
  267. TABLE 253 RECKITT BENCKISER: PRODUCT OFFERED
  268. TABLE 254 CHURCH & DWIGHT CO., INC.: PRODUCT OFFERED
  269. TABLE 255 ABBVIE INC.: PRODUCT OFFERED
  270. TABLE 256 ORGANON & CO.: PRODUCT OFFERED
  271. TABLE 257 MERCK & CO.: PRODUCT OFFERED
  272. TABLE 258 FERRING PHARMACEUTICALS: PRODUCT OFFERED
  273. TABLE 259 AMGEN: PRODUCT OFFERED
  274. LIST OF FIGURES
  275. FIGURE 1 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL WOMEN’S HEALTH MARKET, 2025
  276. FIGURE 2 GLOBAL WOMEN’S HEALTH MARKET ANALYSIS, BY PRODUCT, 2025 (USD MILLION AND %)
  277. FIGURE 3 GLOBAL WOMEN’S HEALTH MARKET ANALYSIS, BY THERAPEUTIC AREA, 2025 (USD MILLION AND %)
  278. FIGURE 4 GLOBAL WOMEN’S HEALTH MARKET ANALYSIS, BY AGE GROUP, 2025 (USD MILLION AND %)
  279. FIGURE 5 GLOBAL WOMEN’S HEALTH MARKET ANALYSIS, BY DISTRIBUTION CHANNEL, 2025 (USD MILLION AND %)
  280. FIGURE 6 GLOBAL WOMEN’S HEALTH MARKET ANALYSIS, BY REGION, 2025 (USD MILLION AND %)
  281. FIGURE 1 GLOBAL WOMEN'S HEALTH MARKET: STRUCTURE
  282. FIGURE 2 GLOBAL WOMEN’S HEALTH MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2036)
  283. FIGURE 3 GLOBAL WOMEN’S HEALTH MARKET DRIVER: IMPACT ANALYSIS
  284. FIGURE 4 GLOBAL WOMEN’S HEALTH MARKET RESTRAINT: IMPACT ANALYSIS
  285. FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL WOMENS HEALTH MARKET
  286. FIGURE 6 GLOBAL WOMEN’S HEALTH MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION)
  287. FIGURE 7 GLOBAL WOMEN’S HEALTH MARKET, BY PRODUCT, 2025 & 2035 (USD MILLION)
  288. FIGURE 8 GLOBAL WOMEN’S HEALTH MARKET SHARE (%), BY PRODUCT, 2025
  289. FIGURE 9 GLOBAL WOMEN’S HEALTH MARKET, THERAPEUTIC AREASEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION)
  290. FIGURE 10 GLOBAL WOMEN’S HEALTH MARKET, BY THERAPEUTIC AREA, 2025 & 2035 (USD MILLION)
  291. FIGURE 11 GLOBAL WOMEN’S HEALTH MARKET SHARE (%), BY THERAPEUTIC AREA, 2025
  292. FIGURE 12 GLOBAL WOMEN’S HEALTH MARKET, AGE GROUP, SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION)
  293. FIGURE 13 GLOBAL WOMEN’S HEALTH MARKET, BY AGE GROUP, 2025 & 2035 (USD MILLION)
  294. FIGURE 14 GLOBAL WOMEN’S HEALTH MARKET SHARE (%), BY AGE GROUP, 2025
  295. FIGURE 15 GLOBAL WOMEN’S HEALTH MARKET, DISTRIBUTION CHANNEL SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION)
  296. FIGURE 16 GLOBAL WOMEN’S HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2025 & 2035 (USD MILLION)
  297. FIGURE 17 GLOBAL WOMEN’S HEALTH MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2025
  298. FIGURE 18 GLOBAL WOMEN’S HEALTH MARKET, BY REGION, 2025 & 2035 (USD MILLION)
  299. FIGURE 19 GLOBAL WOMEN’S HEALTH MARKET SHARE (%), BY REGION, 2025
  300. FIGURE 20 NORTH AMERICA MARKET ANALYSIS: WOMEN’S HEALTH MARKET, 2019-2035 (USD MILLION)
  301. FIGURE 21 NORTH AMERICA WOMEN’S HEALTH MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION)
  302. FIGURE 22 NORTH AMERICA WOMEN’S HEALTH MARKET SHARE (%), BY COUNTRY, 2025
  303. FIGURE 23 EUROPE MARKET ANALYSIS: WOMEN’S HEALTH MARKET, 2019-2035 (USD MILLION)
  304. FIGURE 24 EUROPE WOMEN’S HEALTH MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION)
  305. FIGURE 25 EUROPE WOMEN’S HEALTH MARKET SHARE (%), BY COUNTRY, 2025
  306. FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: WOMEN’S HEALTH MARKET, 2019-2035 (USD MILLION)
  307. FIGURE 27 ASIA-PACIFIC WOMEN’S HEALTH MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION)
  308. FIGURE 28 ASIA-PACIFIC WOMEN’S HEALTH MARKET SHARE (%), BY COUNTRY, 2025
  309. FIGURE 29 LATIN AMERICA MARKET ANALYSIS: WOMEN’S HEALTH MARKET, 2019-2035 (USD MILLION)
  310. FIGURE 30 LATIN AMERICA WOMEN’S HEALTH MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION)
  311. FIGURE 31 LATIN AMERICA WOMEN’S HEALTH MARKET SHARE (%), BY COUNTRY, 2025
  312. FIGURE 32 MIDDLE EAST & AFRICA MARKET ANALYSIS: WOMEN’S HEALTH MARKET, 2019-2035 (USD MILLION)
  313. FIGURE 33 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION)
  314. FIGURE 34 MIDDLE EAST & AFRICA WOMEN’S HEALTH MARKET SHARE (%), BY COUNTRY, 2025
  315. FIGURE 35 GLOBAL WOMEN’S HEALTHS MARKET: COMPETITIVE ANALYSIS, 2025 (%)
  316. FIGURE 36 COMPETITOR DASHBOARD: GLOBAL WOMEN’S HEALTH MARKET
  317. FIGURE 37 BAYER AG: SWOT ANALYSIS
  318. FIGURE 38 MERCK KGAA: SWOT ANALYSIS
  319. FIGURE 39 PFIZER: SWOT ANALYSIS
  320. FIGURE 40 RECKITT BENCKISER: SWOT ANALYSIS
  321. FIGURE 41 CHURCH & DWIGHT CO., INC.: SWOT ANALYSIS
  322. FIGURE 42 ABBVIE INC.: SWOT ANALYSIS
  323. FIGURE 43 ORGANON & CO.: SWOT ANALYSIS
  324. FIGURE 44 MERCK & CO.: SWOT ANALYSIS
  325. FIGURE 45 FERRING PHARMACEUTICALS: SWOT ANALYSIS
  326. FIGURE 46 AMGEN.: SWOT ANALYSIS

Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)

  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others

Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)

  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others

Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)

  • Below 30
  • 31-40
  • 41-50
  • Above 51

Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others

Women’s Health Market Regional Outlook (USD Million, 2019-2035)

  • North America Outlook (USD Million, 2019-2035)
  • North America Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • North America Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • North America Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • North America Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • US Outlook (USD Million, 2019-2035)
  • US Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • US Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • US Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • US Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Canada Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others   
  • Europe Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • GermanyOutlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • UK Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others

 

    • France Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Russia Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Italy Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Spain Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Rest Of Europe Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
  • Asia-Pacific Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • China Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others 
    • India Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Japan Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • South Korea Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
  • South America Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Mexico Outlook (USD Million, 2019-2035)
  • Global Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Global Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Global Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Global Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Argentina Outlook (USD Million, 2019-2035)
  • Global Consulting services Market by Service Type Outlook (USD Million, 2019-2035)
  • IT Strategy & Advisory
  • Digital Transformation Consulting
  • Cloud & Infrastructure Consulting
  • Data & AI Consulting
  • Cybersecurity Consulting
  • ERP & Enterprise Applications Consulting
  • Managed Technology Services
  • Emerging Technology Services (Blockchain, IoT, AR/ VR, Edge Computing, Quantum Computing Advisory)
  • Global Consulting services Market by Engagement Model Outlook (USD Million, 2019-2035)
  • Project-based
  • Retainer-based
  • Managed Services/ Subscription Model
  • Hybrid/ Blended Engagement Models
  • Global Consulting services Market by Organization Size Outlook (USD Million, 2019-2035)
  • Large Enterprises
  • Small-Medium Enterprises (SMEs)
  • Global Consulting services Market by Industry vertical Outlook (USD Million, 2019-2035)
  • Banking, Financial Services & Insurance (BFSI)
  • Healthcare
  • Manufacturing
  • Retail & E-Commerce
  • Telecommunications
  • Energy & Utilities
  • Government & Public Sector
  • Media & Entertainment
  • Others
  • Civilian
    • Rest of South America Outlook (USD Million, 2019-2035)
  • Global Consulting services Market by Service Type Outlook (USD Million, 2019-2035)
  • IT Strategy & Advisory
  • Digital Transformation Consulting
  • Cloud & Infrastructure Consulting
  • Data & AI Consulting
  • Cybersecurity Consulting
  • ERP & Enterprise Applications Consulting
  • Managed Technology Services
  • Emerging Technology Services (Blockchain, IoT, AR/ VR, Edge Computing, Quantum Computing Advisory)
  • Global Consulting services Market by Engagement Model Outlook (USD Million, 2019-2035)
  • Project-based
  • Retainer-based
  • Managed Services/ Subscription Model
  • Hybrid/ Blended Engagement Models
  • Global Consulting services Market by Organization Size Outlook (USD Million, 2019-2035)
  • Large Enterprises
  • Small-Medium Enterprises (SMEs)
  • Global Consulting services Market by Industry vertical Outlook (USD Million, 2019-2035)
  • Banking, Financial Services & Insurance (BFSI)
  • Healthcare
  • Manufacturing
  • Retail & E-Commerce
  • Telecommunications
  • Energy & Utilities
  • Government & Public Sector
  • Media & Entertainment
  • Others
  • Civilian  
  • Middle East & Africa Outlook (USD Million, 2019-2035)
  • Global Consulting services Market by Service Type Outlook (USD Million, 2019-2035)
  • IT Strategy & Advisory
  • Digital Transformation Consulting
  • Cloud & Infrastructure Consulting
  • Data & AI Consulting
  • Cybersecurity Consulting
  • ERP & Enterprise Applications Consulting
  • Managed Technology Services
  • Emerging Technology Services (Blockchain, IoT, AR/ VR, Edge Computing, Quantum Computing Advisory)
  • Global Consulting services Market by Engagement Model Outlook (USD Million, 2019-2035)
  • Project-based
  • Retainer-based
  • Managed Services/ Subscription Model
  • Hybrid/ Blended Engagement Models
  • Global Consulting services Market by Organization Size Outlook (USD Million, 2019-2035)
  • Large Enterprises
  • Small-Medium Enterprises (SMEs)
  • Global Consulting services Market by Industry vertical Outlook (USD Million, 2019-2035)
  • Banking, Financial Services & Insurance (BFSI)
  • Healthcare
  • Manufacturing
  • Retail & E-Commerce
  • Telecommunications
  • Energy & Utilities
  • Government & Public Sector
  • Media & Entertainment
  • Others
  • Civilian
    • GCC Countries Outlook (USD Million, 2019-2035)
  • Global Consulting services Market by Service Type Outlook (USD Million, 2019-2035)
  • IT Strategy & Advisory
  • Digital Transformation Consulting
  • Cloud & Infrastructure Consulting
  • Data & AI Consulting
  • Cybersecurity Consulting
  • ERP & Enterprise Applications Consulting
  • Managed Technology Services
  • Emerging Technology Services (Blockchain, IoT, AR/ VR, Edge Computing, Quantum Computing Advisory)
  • Global Consulting services Market by Engagement Model Outlook (USD Million, 2019-2035)
  • Project-based
  • Retainer-based
  • Managed Services/ Subscription Model
  • Hybrid/ Blended Engagement Models
  • Global Consulting services Market by Organization Size Outlook (USD Million, 2019-2035)
  • Large Enterprises
  • Small-Medium Enterprises (SMEs)
  • Global Consulting services Market by Industry vertical Outlook (USD Million, 2019-2035)
  • Banking, Financial Services & Insurance (BFSI)
  • Healthcare
  • Manufacturing
  • Retail & E-Commerce
  • Telecommunications
  • Energy & Utilities
  • Government & Public Sector
  • Media & Entertainment
  • Others
  • Civilian
    • South Africa Outlook (USD Million, 2019-2035)
  • South Africa Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • South Africa Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • South Africa Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • South Africa Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others
    • Rest of Middle East & Africa Outlook (USD Million, 2019-2035)
  • Rest of Middle East & Africa Women’s Health Market by Product Outlook (USD Million, 2019-2035)
  • Contraceptives
  • Fertility and Ovulation Induction Drugs
  • Vaginal and Uterine Products
  • Bone Health Agents
  • Pain and Symptom Management
  • Others
  • Rest of Middle East & Africa Women’s Health Market by Therapeutic Area Outlook (USD Million, 2019-2035)
  • Reproductive Health and Fertility
  • Menopause and Hormonal Disorders
  • Gynecological Disorders
  • Others
  • Rest of Middle East & Africa Women’s Health Market by Age Group Outlook (USD Million, 2019-2035)
  • Below 30
  • 31-40
  • 41-50
  • Above 51
  • Rest of Middle East & Africa Women’s Health Market by Distribution Channel Outlook (USD Million, 2019-2035)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Supermarket and Hypermarket
  • Online Channels
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions